The American Urological Association (AUA) has updated its BPH Surgical Management Guidelines. The Guidelines include 22 Clinical Recommendations. We have highlighted four important Guideline principals that support practices using SRS Medical solutions to drive better BPH care. Principal 1: The recommendation that BPH Procedures should be delayed until Medical Management failure has been eliminated. Guideline language “…clinical scenarios where surgery is indicated as the initial intervention for LUTS/BPH and should be recommended, providing other medical comorbidities do not preclude this approach.” SRS Medical perspective The previous AUA Guidelines recommended procedures only after medical management failure. The new Guidelines recommend consideration of earlier intervention via expanded procedure options and better diagnostics. Principal 2: Pressure flow studies should be considered prior to intervention. Guideline language “Clinicians should consider pressure flow studies prior to surgical intervention for LUTS attributed to BPH when diagnostic uncertainty exists. (Expert Opinion)” SRS Medical perspective Diagnosing bladder function provides a physiological marker to establish a patient’s position in the BPH disease state. Interventions should occur before bladder function deteriorates, independent of symptom tolerance. Principal 3: Both the UroLift and Rezum procedures are established standards of care. Guideline language Guideline statements 14,15,17,18. Principal 4: AUA emphasizes expanded diagnostics in the future Guideline language “The natural history and predictive ability of various urodynamic measures, [….] is an area of great interest with substantial clinical and health care economic consequences.” SRS Medical perspective AUA has determined that bladder function diagnostics play a critical role in BPH management. They also indicate that the role of bladder function diagnostics will continue to expand. SRS Medical is leading the way. ![]()
0 Comments
|
ArchivesCategories
All
|